These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 3796791)
21. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release. Zhao BG; Chapman C; Bicknell RJ Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291 [TBL] [Abstract][Full Text] [Related]
22. NO inhibition of the magnocellular neuroendocrine system in rats is independent of cGMP signaling pathway. Terrell ML; Salas N; Bui V; Summy-Long JY; Kadekaro M Exp Neurol; 2003 Dec; 184(2):846-56. PubMed ID: 14769377 [TBL] [Abstract][Full Text] [Related]
23. The effect of opioid antagonism and environmental restriction on plasma oxytocin and vasopressin concentrations in parturient gilts. Jarvis S; Lawrence AB; McLean KA; Chirnside J; Deans LA; Calvert SK; Gilbert CL; Goode JA; Forsling ML J Endocrinol; 2000 Jul; 166(1):39-44. PubMed ID: 10856881 [TBL] [Abstract][Full Text] [Related]
24. Interruption of parturition in rats by morphine: a result of inhibition of oxytocin secretion. Russell JA; Gosden RG; Humphreys EM; Cutting R; Fitzsimons N; Johnston V; Liddle S; Scott S; Stirland JA J Endocrinol; 1989 Jun; 121(3):521-36. PubMed ID: 2754376 [TBL] [Abstract][Full Text] [Related]
25. Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study. Neumann I; Russell JA; Wolff B; Landgraf R Neuroendocrinology; 1991 Dec; 54(6):545-51. PubMed ID: 1784342 [TBL] [Abstract][Full Text] [Related]
26. Effects of centrally administered endogenous opioid peptides on drinking behavior, increased plasma vasopressin concentration and pressor response to hypertonic sodium chloride. Summy-Long JY; Rosella LM; Keil LC Brain Res; 1981 Sep; 221(2):343-57. PubMed ID: 6269692 [TBL] [Abstract][Full Text] [Related]
27. Central inhibition of nitric oxide synthase attenuates water intake but does not alter enhanced glucose utilization in the hypothalamo-neurohypophysial system of dehydrated rats. Kadekaro M; Terrell ML; Harmann P; Summy-Long JY Neurosci Lett; 1994 May; 173(1-2):115-8. PubMed ID: 7523994 [TBL] [Abstract][Full Text] [Related]
28. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats. Iványi T; Dohanics J; Verbalis JG Neuroendocrinology; 1995 Apr; 61(4):412-20. PubMed ID: 7783854 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological assessment of the site of action of opioids on the release of vasopressin and oxytocin in the rat. Van de Heijning BJ; Koekkoek-Van den Herik I; Maigret C; Van Wimersma Greidanus TB Eur J Pharmacol; 1991 May; 197(2-3):175-80. PubMed ID: 1680708 [TBL] [Abstract][Full Text] [Related]
30. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe. Bondy CA; Gainer H; Russell JT Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296 [TBL] [Abstract][Full Text] [Related]
31. Contribution of the region anterior and ventral to the third ventricle to opiate withdrawal excitation of oxytocin secretion. Russell JA; Pumford KM; Bicknell RJ Neuroendocrinology; 1992 Feb; 55(2):183-92. PubMed ID: 1620286 [TBL] [Abstract][Full Text] [Related]
32. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats. Ciosek J; Cisowska A J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616 [TBL] [Abstract][Full Text] [Related]
33. A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin. Summy-Long JY; Miller DS; Rosella-Dampman LM; Hartman RD; Emmert SE Brain Res; 1984 Sep; 309(2):362-6. PubMed ID: 6541075 [TBL] [Abstract][Full Text] [Related]
34. Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects. Aubert JF; Burnier M; Waeber B; Nussberger J; Brunner HR J Pharmacol Exp Ther; 1987 Nov; 243(2):681-5. PubMed ID: 3681699 [TBL] [Abstract][Full Text] [Related]
35. Influence of thyroliberin (TRH) on hypothalamo-neurohypophysial vasopressin and oxytocin content of rats drinking 2% NaCl. Ciosek J Patol Pol; 1993; 44(4):221-6. PubMed ID: 8309734 [TBL] [Abstract][Full Text] [Related]
36. The hypothalamic and neurohypophysial vasopressin and oxytocin content under various states of adrenergic transmission in dehydrated and subsequently rehydrated rats. Ciosek J; Guzek JW; Morawska J Acta Physiol Pol; 1985; 36(4):229-41. PubMed ID: 3019081 [TBL] [Abstract][Full Text] [Related]
37. Effect of naloxone on oxytocin and vasopressin release during vaginocervical stimulation in the goat. Seckl JR; Lightman SL J Endocrinol; 1987 Nov; 115(2):317-22. PubMed ID: 3437251 [TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin octapeptide and the daily rhythm of vasopressin and oxytocin release. Morawska-Barszczewska J; Guzek JW; Kaczorowska-Skóra J Exp Clin Endocrinol Diabetes; 1996; 104(2):164-71. PubMed ID: 8740941 [TBL] [Abstract][Full Text] [Related]
39. Opioid-noradrenergic interactions in the neurohypophysis. II. Does noradrenaline mediate the actions of endogenous opioids on oxytocin and vasopressin release? Zhao BG; Chapman C; Brown D; Bicknell RJ Neuroendocrinology; 1988 Jul; 48(1):25-31. PubMed ID: 2845292 [TBL] [Abstract][Full Text] [Related]
40. Response of interleukin-1beta in the magnocellular system to salt-loading. Summy-Long JY; Hu S; Pruss A; Chen X; Phillips TM J Neuroendocrinol; 2006 Dec; 18(12):926-37. PubMed ID: 17076768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]